Brief: Kuros To Get $2 Mln Payment From Checkmate Pharmaceuticals
April 6 (Reuters) - KUROS BIOSCIENCES AG KURN.S :
* KUROS TO RECEIVE $2 MILLION MILESTONE PAYMENT FROM
CHECKMATE
PHARMACEUTICALS
* KUROS STANDS TO RECEIVE UP TO $56 MILLION MILESTONES PLUS
ROYALTIES ON SALES
* MILESTONE RELATED TO CHECKMATE DOSING FIRST PATIENT IN A
PHASE 2
MELANOMA TRIAL WITH CMP-001
Further company coverage: KURN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million